Interleukin-37 in endometriosis

Immunology Letters

Volumn 185, Issue , 2017, Pages 52-55

  Kaabachi, Wajih ^a,b   Kacem, Olfa ^a,b   Belhaj, Rafik ^a,b   Hamzaoui, Agnes ^a,b   Hamzaoui, Kamel ^a,b  

^a ABDERRAHMAN MAMI HOSPITAL   (Tunisia)

^b UNIVERSITY OF TUNIS EL MANAR   (Tunisia)

Author keywords

Endometriosis; IL 17; IL 33; IL 37; Inflammation; NF B

Indexed keywords

CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 37; MESSENGER RNA; TUMOR NECROSIS FACTOR; IL37 PROTEIN, HUMAN; INTERLEUKIN 1;

ADAPTIVE IMMUNITY; ADULT; ARTICLE; BINDING AFFINITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RESPONSE; DISEASE SEVERITY; ENDOMETRIOSIS; ENDOMETRIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HELPER CELL; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; PATHOGENESIS; PERITONEAL FLUID; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA TRANSCRIPTION; TH1 CELL; TH2 CELL; ASCITES FLUID; BLOOD; GENETICS; IMMUNOLOGY; METABOLISM; YOUNG ADULT;

ADULT; ASCITIC FLUID; ENDOMETRIOSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERLEUKIN-1; NF-KAPPA B; RNA, MESSENGER; YOUNG ADULT;

EID: 85015981268     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2017.03.012     Document Type: Article

References (26)

1. [1] Ponce, C., Torres, M., Galleguillos, C., Sovino, H., Boric, M.A., Fuentes, A., Johnson, M.C., Nuclear factor kappab pathway and interleukin-6 are affected in eutopic endometrium of women with endometriosis. Reproduction 137:4 (2009), 727–737.
2. [2] Podgaec, S., Abrao, M.S., Dias, J.A. Jr., Rizzo, L.V., de Oliveira, R.M., Baracat, E.C., Endometriosis: an inflammatory disease with a Th2 immune response component. Hum. Reprod. 22:5 (2007), 1373–1379.
3. [3] May, K.E., Conduit-Hulbert, S.A., Villar, J., Kirtley, S., Kennedy, S.H., Becker, C.M., Peripheral biomarkers of endometriosis: a systematic review. Hum. Reprod. Update 16:6 (2010), 651–674.
4. [4] Mbarik, M., Kaabachi, W., Henidi, B., Sassi, F.H., Hamzaoui, K., Soluble ST2 and IL-33: potential markers of endometriosis in the Tunisian population. Immunol. Lett. 166:1 (2015), 1–5.
5. [5] Komai-Koma, M., Xu, D., Li, Y., McKenzie, A.N., McInnes, I.B., Liew, F.Y., Il-33 is a chemoattractant for human Th2Cells. Eur. J. Immunol. 37:10 (2007), 2779–2786.
6. [6] Jiang, J.F., Deng, Y., Xue, W., Zheng, T.P., Sun, A.J., Increased expression of interleukin 37 in the eutopic and ectopic endometrium of patients with ovarian endometriosis. Reprod. Sci. 23:2 (2016), 244–248.
7. [7] Gonzalez-Ramos, R., Donnez, J., Defrere, S., Leclercq, I., Squifflet, J., Lousse, J.C., Van Langendonckt, A., Nuclear factor-kappa B is constitutively activated in peritoneal endometriosis. Mol. Hum. Reprod. 13:7 (2007), 503–509.
8. [8] Nold, M.F., Nold-Petry, C.A., Zepp, J.A., Palmer, B.E., Bufler, P., Dinarello, C.A., Il-37 is a fundamental inhibitor of innate immunity. Nat. Immunol. 11:11 (2010), 1014–1022.
9. [9] Bulau, A.M., Nold, M.F., Li, S., Nold-Petry, C.A., Fink, M., Mansell, A., Schwerd, T., Hong, J., Rubartelli, A., Dinarello, C.A., Bufler, P., Role of caspase-1 in nuclear translocation of Il-37, release of the cytokine, and Il-37 inhibition of innate immune responses. Proc. Natl. Acad. Sci. U. S. A. 111:7 (2014), 2650–2655.
10. [10] Nold-Petry, C.A., Lo, C.Y., Rudloff, I., Elgass, K.D., Li, S., Gantier, M.P., IL-37 requires the receptors IL-18Rα and IL-1R8 (SIGIRR) to carry out its multifaceted anti-inflammatory program upon innate signal transduction. Nat. Immunol. 16:4 (2015), 354–365.
11. [11] Xie, Y., Li, Y., Cai, X., Wang, X., Li, J., Interleukin-37 suppresses Icam-1 expression in parallel with Nf-kappab down-regulation following Tlr2 activation of human coronary artery endothelial cells. Int. Immunopharmacol. 38 (2016), 26–30.
12. [12] Bouali, E., Kaabachi, W., Hamzaoui, A., Hamzaoui, K., Interleukin-37 expression is decreased in Behcet's disease and is associated with inflammation. Immunol. Lett. 167:2 (2015), 87–94.
13. [13] Charrad, R., Berraies, A., Hamdi, B., Ammar, J., Hamzaoui, K., Hamzaoui, A., Anti-inflammatory activity of Il-37 in asthmatic children: correlation with inflammatory cytokines Tnf-alpha, Il-beta, Il-6 and Il-17a. Immunobiology 221:2 (2016), 182–187.
14. [14] Richter, K., Holz, O., Jorres, R.A., Mucke, M., Magnussen, H., Sequentially induced sputum in patients with asthma or chronic obstructive pulmonary disease. Eur. Respir. J. 14:3 (1999), 697–701.
15. [15] Renard, P., Ernest, I., Houbion, A., Art, M., Le Calvez, H., Raes, M., Remacle, J., Development of a sensitive multi-well colorimetric assay for active Nfkappab. Nucleic Acids Res., 29(4), 2001, E21.
16. [16] Hamzaoui, K., Kaabachi, W., Fazaa, B., Zakraoui, L., Mili-Boussen, I., Haj-Sassi, F., Serum Il-33 levels and skin mRNA expression in Behcet's disease. Clin. Exp. Rheumatol. 31:3 (2013), 6–14.
17. [17] Nile, C.J., Barksby, E., Jitprasertwong, P., Preshaw, P.M., Taylor, J.J., Expression and regulation of interleukin-33 in human monocytes. Immunology 130:2 (2010), 172–180.
18. [18] Jerzak, M., Baranowski, W., Rechberger, T., Gorski, A., Enhanced T cells interactions with extracellular matrix proteins in infertile women with endometriosis. Immunol. Lett. 81:1 (2002), 65–70.
19. [19] Prefumo, F., Semino, C., Melioli, G., Venturini, P.L., A defective expression of Icam-1 (Cd54) on secretory endometrial cells is associated with endometriosis. Immunol. Lett. 80:1 (2002), 49–53.
20. [20] Eisenberg, V.H., Zolti, M., Soriano, D., Is there an association between autoimmunity and endometriosis?. Autoimmun. Rev. 11:11 (2012), 806–814.
21. [21] Xu, W.D., Zhao, Y., Liu, Y., Insights into Il-37, the role in autoimmune diseases. Autoimmun. Rev. 14:12 (2015), 1170–1175.
22. [22] Ding, V.A., Zhu, Z., Mantz, A.A., Xiao, H., Wakefield, M.R., Bai, Q., Fang, Y., The role of IL-37 in Non-Cancerous Diseases. Pathol. Oncol. Res., 2016, 10.1007/s12253-016-0137-7.
23. [23] Wang, W.Q., Dong, K., Zhou, L., Jiao, G.H., Zhu, C.Z., Li, W.W., Yu, G., Wu, W.T., Chen, S., Sun, Z.N., Wang, Y.M., Liu, W.T., Zhang, J., Wang, B.M., Feng, X.M., Il-37b gene transfer enhances the therapeutic efficacy of mesenchumal stromal cells in Dss-induced colitis mice. Acta Pharmacol. Sin. 36:11 (2015), 1377–1387.
24. [24] Fonseca-Camarillo, G., Furuzawa-Carballeda, J., Yamamoto-Furusho, J.K., Interleukin 35 (Il-35) and Il-37: intestinal and peripheral expression by T and B regulatory cells in patients with inflammatory bowel disease. Cytokine 75:2 (2015), 389–402.
25. [25] Imaeda, H., Takahashi, K., Fujimoto, T., Kasumi, E., Ban, H., Bamba, S., Sonoda, H., Shimizu, T., Fujiyama, Y., Andoh, A., Epithelial expression of interleukin-37b in inflammatory bowel disease. Clin. Exp. Immunol. 172:3 (2013), 410–416.
26. [26] Wu, W., Wang, W., Wang, Y., Li, W., Yu, G., Li, Z., Fang, C., Shen, Y., Sun, Z., Han, L., Yu, J., Fang, L., Chen, S., Dong, K., Han, Z., Liu, H., Luo, Y., Feng, X., IL-37b suppresses T cell priming by modulating dendritic cell maturation and cytokine production via dampening Erk/Nf-Kappab/S6k signalings. Acta Biochim. Biophys. Sin. (Shanghai) 47:8 (2015), 597–603.